ANDERSON DAVID WESLEY
No ORCID on file
· 20 papers in corpus
· active 2001-2002
Frequent coauthors
- BHAGWAT SHRIPAD S 20
- DOUBLEDAY MARY 20
- GAYO-FUNG LEAH M 20
- JALLURI RAVI KUMAR 20
- KOIS ADAM 20
- KHAMMUNGKHUNE SAK 20
- MCKIE JEFFREY A 20
- SHEVLIN GRAZIELLA I 20
- STEIN BERND M 20
- SUTHERLAND MAY S 10
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2002
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods are…
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …
2001
Compounds that modulate gene expression through the estrogen receptor (ER) are disclosed having the following structure, as well as pharmaceutical compositions containing the same:wherein R1, R2, R3, n and p are as defined here. Methods …